Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1)

PHASE3CompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2014

Conditions
Iron Deficiency AnaemiaInflammatory Bowel DiseaseUlcerative Colitis
Interventions
DRUG

ST10-021

30 mg capsules to be taken orally twice a day for 12 weeks

DRUG

Placebo Comparator

Matching sugar pill to be taken orally twice a day for 12 weeks

Sponsors
All Listed Sponsors
lead

Shield Therapeutics

INDUSTRY

NCT01340872 - Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1) | Biotech Hunter | Biotech Hunter